denkapparat Operations GmbH bought a new position in Colgate-Palmolive (NYSE:CL – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 3,670 shares of the company’s stock, valued at approximately $334,000.
A number of other hedge funds have also added to or reduced their stakes in the stock. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at $26,000. Centricity Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter worth about $27,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $32,000. Briaud Financial Planning Inc bought a new position in shares of Colgate-Palmolive in the 4th quarter worth $32,000. Finally, Wintrust Investments LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at $33,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Wall Street Analyst Weigh In
CL has been the topic of several research reports. Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. Barclays boosted their target price on Colgate-Palmolive from $83.00 to $89.00 and gave the company an “equal weight” rating in a research note on Thursday. Raymond James restated an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Morgan Stanley decreased their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $102.06.
Colgate-Palmolive Price Performance
Shares of CL stock opened at $93.25 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market cap of $75.68 billion, a price-to-earnings ratio of 26.49, a PEG ratio of 4.20 and a beta of 0.40. The business’s fifty day moving average is $89.62 and its 200 day moving average is $93.80. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company posted $0.87 earnings per share. Research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive announced that its board has approved a stock buyback program on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.
Colgate-Palmolive Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date is Thursday, April 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.23%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. Colgate-Palmolive’s dividend payout ratio is presently 59.09%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Stock Sentiment Analysis: How it Works
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellÂ
- What is Short Interest? How to Use It
- Top 3 Beverage Stocks Pouring Out Profits
- How to Use High Beta Stocks to Maximize Your Investing Profits
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.